Photograph by Guillaume Binet/MYOP
HIV & opportunistic infection treatment: Spotlight on access gaps
This issue brief provides information regarding the changing product landscape, and updates on pricing and access to three critical medical interventions: optimal HIV therapy with dolutegravir; paediatric HIV therapy; and opportunities to improve treatment for two common opportunistic infections: cryptococcal meningitis and Kaposi’s sarcoma.
Additional publications in the Untangling the Web report series are available here.
Learn more about MSF’s work to improve access to lifesaving HIV treatment.